Evidence map›Paper›PMID 42121324›Full record

ArticleMedical physics2026

Advancing iris melanoma brachytherapy: Eye plaque models for Monte Carlo simulations and 3D dosimetric datasets.

Marwa Djedouani, Alex Viner, Elizabeth M Fletcher, Rowan M Thomson

Abstract read
In one paragraph

Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Marwa DjedouaniCarleton Laboratory for Radiotherapy Physics, Department of Physics, Carleton University, Ottawa, Ontario, Canada.
Alex VinerCarleton Laboratory for Radiotherapy Physics, Department of Physics, Carleton University, Ottawa, Ontario, Canada.
Elizabeth M FletcherCarleton Laboratory for Radiotherapy Physics, Department of Physics, Carleton University, Ottawa, Ontario, Canada.
Rowan M ThomsonCarleton Laboratory for Radiotherapy Physics, Department of Physics, Carleton University, Ottawa, Ontario, Canada.

Funding

CIHR 437591Natural Sciences and Engineering Research Council of Canada 2024-05355
6 · The paper itself

Abstract

purposeTo develop and benchmark eye plaque models for Monte Carlo (MC) simulation of iris melanoma brachytherapy and to develop a database of 3D dose distributions for the iris plaques containing ACQUISITION AND VALIDATION

methodsFive iris plaque models are developed with egs_brachy using published dimensions and material data; previously benchmarked seed models are used. Three plaque models are based on those used by the Mayo Clinic, consisting of a modification of the COMS 22 mm plaque design with a 10 mm void in the center surrounded by an inner collimating lip; plaques span DATA FORMAT AND USAGE NOTES: The eye plaque models will be distributed with egs_brachy on GitHub (https://github.com/clrp-code/egs_brachy), along with an input file to facilitate custom simulations. The dosimetric database (https://doi.org/10.5281/zenodo.14776641) is comprised of 3D dose distributions for each plaque type, simulation condition, and radionuclides. POTENTIAL APPLICATIONS: The iris plaque models enable custom simulations with the open-access egs_brachy code. The database of 3D dose distributions supports advanced dose evaluations, as recommended by AAPM Task Group 221 on Ocular Brachytherapy. Overall, this work supports adoption of model-based dose evaluations for brachytherapy as recommended by TG-186.

Indexed as

BrachytherapyIris NeoplasmsMelanomaMonte Carlo MethodHumansPhantoms, ImagingRadiometryRadiotherapy DosageRadiotherapy Planning, Computer-Assisteddose calculationeye plaque brachytherapyiris melanomaMonte Carlo

Identifiers

PMID42121324
PMCPMC13168379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.